For plaintiffs in Xarelto litigation, the third time was not the charm.

A jury in the third bellwether trial over the blood thinner Xarelto has sided with defendants Janssen Pharmaceuticals Inc. and Bayer—again. The verdict, rendered on Friday, came about three hours after the jury began deliberating and despite the absence of star defense attorney Beth Wilkinson. The trial also was in Jackson, Mississippi, not New Orleans.